Agios Pharmaceuticals Inc (AGIO)
29.46
+0.02
(+0.08%)
USD |
NASDAQ |
Apr 19, 13:59
Agios Pharmaceuticals Net Income (TTM): -352.09M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -352.09M |
| September 30, 2023 | -219.62M |
| June 30, 2023 | -210.04M |
| March 31, 2023 | -218.04M |
| December 31, 2022 | -231.80M |
| September 30, 2022 | -362.95M |
| June 30, 2022 | -369.97M |
| March 31, 2022 | -364.38M |
| December 31, 2021 | 1.605B |
| September 30, 2021 | 1.602B |
| June 30, 2021 | 1.591B |
| March 31, 2021 | 1.587B |
| December 31, 2020 | -327.37M |
| September 30, 2020 | -332.06M |
| June 30, 2020 | -339.26M |
| March 31, 2020 | -358.65M |
| December 31, 2019 | -411.47M |
| September 30, 2019 | -400.92M |
| June 30, 2019 | -389.41M |
| March 31, 2019 | -348.28M |
| December 31, 2018 | -346.03M |
| September 30, 2018 | -342.52M |
| June 30, 2018 | -324.99M |
| Date | Value |
|---|---|
| March 31, 2018 | -339.33M |
| December 31, 2017 | -314.67M |
| September 30, 2017 | -282.87M |
| June 30, 2017 | -268.57M |
| March 31, 2017 | -241.44M |
| December 31, 2016 | -198.47M |
| September 30, 2016 | -182.61M |
| June 30, 2016 | -160.03M |
| March 31, 2016 | -135.97M |
| December 31, 2015 | -117.73M |
| September 30, 2015 | -103.78M |
| June 30, 2015 | -59.81M |
| March 31, 2015 | -46.21M |
| December 31, 2014 | -53.50M |
| September 30, 2014 | -39.22M |
| June 30, 2014 | -54.10M |
| March 31, 2014 | -44.43M |
| December 31, 2013 | -39.41M |
| September 30, 2013 | -32.34M |
| June 30, 2013 | -25.81M |
| March 31, 2013 | -22.70M |
| December 31, 2012 | -20.10M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-411.47M
Minimum
Dec 2019
1.605B
Maximum
Dec 2021
78.79M
Average
-332.06M
Median
Sep 2020
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals Inc | -440.24M |
| Blueprint Medicines Corp | -506.98M |
| Corcept Therapeutics Inc | 106.14M |
| Ionis Pharmaceuticals Inc | -366.29M |
| Madrigal Pharmaceuticals Inc | -373.63M |